UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

The New England journal of medicine, 2021-02, Vol.384 (7), p.630-642

2021

Volltextzugriff (PDF)

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials

American journal of obstetrics and gynecology, 2023-03, Vol.228 (3), p.320.e1-320.e11

2023

Volltextzugriff (PDF)

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Fertility and sterility, 2017-07, Vol.108 (1), p.152-160.e4

2017

Volltextzugriff (PDF)

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Obstetrics and gynecology (New York. 1953), 2022-12, Vol.140 (6), p.920-930

2022

Volltextzugriff (PDF)

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (5), p.869-878

2019

Volltextzugriff (PDF)

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

American journal of obstetrics and gynecology, 2023-12, Vol.229 (6), p.662.e1-662.e25

2023

Volltextzugriff (PDF)

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

International journal of gynecology and obstetrics, 2024-05, Vol.165 (2), p.431-441

2024

Volltextzugriff (PDF)

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

American journal of obstetrics and gynecology, 2024-02, Vol.230 (2), p.237.e1-237.e11

2024

Volltextzugriff (PDF)

Twelve-Month Outcomes for Patients Undergoing Hysteroscopic Morcellation of Uterine Polyps and Myomas in an Office or Ambulatory Surgical Center

Journal of minimally invasive gynecology, 2015-02, Vol.22 (2), p.285-290

2015

Volltextzugriff (PDF)

Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2010-10, Vol.116 (4), p.865-875

2010

Volltextzugriff (PDF)

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

Fertility and sterility, 2008-09, Vol.90 (3), p.673-677

2008

Volltextzugriff (PDF)

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

British journal of haematology, 2009-04, Vol.145 (2), p.212-220

2009

Volltextzugriff (PDF)

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies

Pain management, 2023-04, Vol.13 (4), p.205-211

2023

Volltextzugriff (PDF)

Postablation risk factors for pain and subsequent hysterectomy

Obstetrics and gynecology (New York. 1953), 2015-04, Vol.125 (4), p.982

Lukes, Andrea

2015

Volltextzugriff (PDF)

A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding

American journal of obstetrics and gynecology, 2011-10, Vol.205 (4), p.319.e1-319.e7

2011

Volltextzugriff (PDF)

Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding

Current medical research and opinion, 2010-11, Vol.26 (11), p.2673-2678

2010

Volltextzugriff (PDF)

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia

American journal of obstetrics and gynecology, 2011-03, Vol.204 (3), p.209.e1-209.e7

2011

Volltextzugriff (PDF)

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Women's health (London, England), 2012-09, Vol.8 (5), p.503-511

2012

Volltextzugriff (PDF)

Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation

Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.607-611

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives

Population health management, 2015-10, Vol.18 (5), p.373-382

2015

Volltextzugriff (PDF)

Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process

Fertility and sterility, 2005-11, Vol.84 (5), p.1335-1337

2005

Volltextzugriff (PDF)

Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact

Fertility and sterility, 2005-11, Vol.84 (5), p.1338-1344

2005

Volltextzugriff (PDF)

The risk of stroke and death in patients with aortic and mitral valve endocarditis

The American heart journal, 2001-07, Vol.142 (1), p.75-80

2001

Volltextzugriff (PDF)

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

Drug safety, 2008, Vol.31 (4), p.275-282

2008

Volltextzugriff (PDF)

Management of excessive menstrual bleeding in women with hemostatic disorders

Fertility and sterility, 2005-11, Vol.84 (5), p.1352-1359

2005

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

Twelve-Month Outcomes for Patients Undergoing Hysteroscopic Morcellation of Uterine Polyps and Myomas in an Office or Ambulatory Surgical Center

Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies

Postablation risk factors for pain and subsequent hysterectomy

A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding

Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives

Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process

Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact

The risk of stroke and death in patients with aortic and mitral valve endocarditis

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

Management of excessive menstrual bleeding in women with hemostatic disorders

Aktive Filter

Suchergebnisse filtern